1. bookAHEAD OF PRINT
Détails du magazine
License
Format
Magazine
eISSN
2501-062X
Première parution
30 Mar 2015
Périodicité
4 fois par an
Langues
Anglais
Accès libre

Effects of underlying heart failure on outcomes of COVID-19; a systematic review and meta-analysis

Détails du magazine
License
Format
Magazine
eISSN
2501-062X
Première parution
30 Mar 2015
Périodicité
4 fois par an
Langues
Anglais

1. ZHU N., ZHANG D., WANG W., LI X., YANG B., SONG J., et al. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020.10.1056/NEJMoa2001017709280331978945 Search in Google Scholar

2. TOMASONI D., ITALIA L., ADAMO M., INCIARDI RM., LOMBARDI CM., SOLOMON SD., et al. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. European journal of heart failure. 2020;22(6):957-66.10.1002/ejhf.1871727309332412156 Search in Google Scholar

3. ZHENG Y-Y., MA Y-T., ZHANG J-Y., XIE X. COVID-19 and the cardiovascular system. Nature reviews cardiology. 2020;17(5):259-60.10.1038/s41569-020-0360-5709552432139904 Search in Google Scholar

4. MADJID M., SAFAVI-NAEINI P., SOLOMON SD., VARDENY O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA cardiology. 2020;5(7):831-40.10.1001/jamacardio.2020.128632219363 Search in Google Scholar

5. CLERKIN KJ., FRIED JA., RAIKHELKAR J., SAYER G., GRIFFIN JM., MASOUMI A., et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648-55.10.1161/CIRCULATIONAHA.120.04694132200663 Search in Google Scholar

6. LIU PP., BLET A., SMYTH D., LI H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142(1):68-78.10.1161/CIRCULATIONAHA.120.04754932293910 Search in Google Scholar

7. XIONG T-Y., REDWOOD S., PRENDERGAST B., CHEN M. Coronaviruses and the cardiovascular system: acute and long-term implications. European heart journal. 2020.10.1093/eurheartj/ehaa231745451332186331 Search in Google Scholar

8. SHI S., QIN M., SHEN B., CAI Y., LIU T., YANG F., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology. 2020;5(7):802-10.10.1001/jamacardio.2020.0950709784132211816 Search in Google Scholar

9. YANGA J., ZHENG Y., GOU X., PU K., CHEN Z., GUO Q., et al. Prevalence of comorbidity and its effects in patients infected with SARS-CoV-2: a systematic review and metaanalysis. Int J Infect Dis. 2020;94:91-5.10.1016/j.ijid.2020.03.017719463832173574 Search in Google Scholar

10. RUMERY K., SEO A., JIANG L., CHOUDHARY G., SHAH NR., RUDOLPH JL., et al. Outcomes of coronavirus disease-2019 among veterans with pre-existing diagnosis of heart failure. ESC Heart Failure. 2021;8(3):2338-44.10.1002/ehf2.13291812038133728800 Search in Google Scholar

11. DEFILIPPIS EM., REZA N., DONALD E., GIVERTZ MM., LINDENFELD J., JESSUP M. Considerations for heart failure care during the COVID-19 pandemic. Heart failure. 2020;8(8):681-91. Search in Google Scholar

12. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). [Internet]. Cochrane. 2022. Available from: Available from www.training.cochrane.org/handbook. Search in Google Scholar

13. YONAS E., ALWI I., PRANATA R., HUANG I., LIM MA., GUTIERREZ EJ., et al. Effect of heart failure on the outcome of COVID-19—A meta analysis and systematic review. The American journal of emergency medicine. 2021;46:204-11.10.1016/j.ajem.2020.07.009734731633071085 Search in Google Scholar

14. LOMBARDI AF., AFSAHI AM., GUPTA A., GHOLAMREZANEZHAD A. Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), influenza, and COVID-19, beyond the lungs: a review article. La radiologia medica. 2021;126(4):561-9.10.1007/s11547-020-01311-x768919033242204 Search in Google Scholar

15. ZHOU B., KOJIMA S., KAWAMOTO A., FUKUSHIMA M. COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. Journal of medical virology. 2021;93(5):2694-704.10.1002/jmv.2675433368358 Search in Google Scholar

16. GUPTA A., MADHAVAN MV., SEHGAL K., NAIR N., MAHAJAN S., SEHRAWAT TS., et al. Extrapulmonary manifestations of COVID-19. Nature medicine. 2020;26(7):1017-32.10.1038/s41591-020-0968-332651579 Search in Google Scholar

17. HAUDHRY F., LAVANDERO S., XIE X., SABHARWAL B., ZHENG Y-Y., CORREA A., et al. Manipulation of ACE2 expression in COVID-19. Open Heart. 2020;7(2):e001424.10.1136/openhrt-2020-001424775741333443121 Search in Google Scholar

18. BABAPOOR-FARROKHRAN S., RASEKHI RT., GILL D., BABAPOOR S., AMANULLAH A. Arrhythmia in COVID-19. SN Comprehensive Clinical Medicine. 2020;2(9):1430-5.10.1007/s42399-020-00454-2742619332838188 Search in Google Scholar

19. SALEH KB., HAFIZ A., ALSULAIMAN K., ALJUHANI O., ALHARBI S., ALHARBI A., et al. Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): a multicenter cohort study. American Heart Journal Plus: Cardiology Research and Practice. 2021;7:100033. Search in Google Scholar

20. TOUSOULIS D., ANTONIADES C., BOSINAKOU E., KOTSOPOULOU M., TSIOUFIS C., TENTOLOURIS C., et al. Effects of atorvastatin on reactive hyperaemia and the thrombosis–fibrinolysis system in patients with heart failure. Heart. 2005;91(1):27-31.10.1136/hrt.2003.027110176864715604328 Search in Google Scholar

21. SHENOY S. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality. Inflammation research. 2020;69(11):1077-85.10.1007/s00011-020-01389-z741096232767095 Search in Google Scholar

22. PAROHAN M., YAGHOUBI S., SERAJI A., JAVANBAKHT MH., SARRAF P., DJALALI M. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The Aging Male. 2020;23(5):1416-24.10.1080/13685538.2020.177474832508193 Search in Google Scholar

23. TOMASONI D., INCIARDI RM., LOMBARDI CM., TEDINO C., AGOSTONI P., AMERI P., et al. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study. European journal of heart failure. 2020;22(12):2238-47.10.1002/ejhf.205233179839 Search in Google Scholar

24. PETRILLI CM., JONES SA., YANG J., RAJAGOPALAN H., O’DONNELL L., CHERNYAK Y., et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. bmj. 2020;369.10.1136/bmj.m1966724380132444366 Search in Google Scholar

25. BOCCHI EA., LIMA IGCV., BISELLI B., SALEMI VMC., FERREIRA SMA., CHIZZOLA PR., et al. Worsening of heart failure by coronavirus disease 2019 is associated with high mortality. ESC Heart Failure. 2021;8(2):943-52.10.1002/ehf2.13199800666133498096 Search in Google Scholar

26. LLÀCER P., MANZANO L., FERNÁNDEZ C., MORENO MC., NÚÑEZ J.. Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis. European Journal of Internal Medicine. 2021;88:136-8.10.1016/j.ejim.2021.02.013790651833676804 Search in Google Scholar

27. RUGE M., GOMEZ JMD., DE LAVALLAZ JDF., HLEPAS A., RAHMAN A., PATEL P., et al. Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19. American heart journal plus: cardiology research and practice. 2021;4:100022.10.1016/j.ahjo.2021.100022820481234151308 Search in Google Scholar

28. SON M., JO YS., JO S., PARK K. Impact of COVID-19 on Heart Failure Patients in South Korea A Nationwide Population-Based Study. International Heart Journal. 2021:21-198.10.1536/ihj.21-19834544986 Search in Google Scholar

29. SOKOLSKI M., TRENSON S., SOKOLSKA JM., D’AMARIO D., MEYER P., POKU NK., et al. Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry. ESC heart failure. 2021;8(6):4955-67.10.1002/ehf2.13549865301434533287 Search in Google Scholar

30. MURAT B., MURAT S., MERT KU., BILGIN M., CAVUSOGLU Y. Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study. Acta cardiologica. 2022;77(1):37-44.10.1080/00015385.2021.194576534218753 Search in Google Scholar

31. GOYAL P., RESHETNYAK E., KHAN S., MUSSE M., NAVI BB., KIM J., et al. Clinical characteristics and outcomes of adults with a history of heart failure hospitalized for COVID-19. Circulation: Heart Failure. 2021;14(9):e008354.10.1161/CIRCHEARTFAILURE.121.008354871164134517720 Search in Google Scholar

32. KUNO T., TAKAHASHI M., OBATA R., MAEDA T. Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City. American heart journal. 2020;226:24-5.10.1016/j.ahj.2020.05.005722757332425197 Search in Google Scholar

33. RUMERY K., SEO A., JIANG L., CHOUDHARY G., SHAH NR., RUDOLPH JL., et al. Outcomes of coronavirus disease-2019 among veterans with pre-existing diagnosis of heart failure. ESC heart failure. 2021;8(3):2338-44.10.1002/ehf2.13291812038133728800 Search in Google Scholar

34. ALVAREZ-GARCIA J., LEE S., GUPTA A., CAGLIOSTRO M., JOSHI AA., RIVASLASARTE M., et al. Prognostic impact of prior heart failure in patients hospitalized with COVID-19. Journal of the American College of Cardiology. 2020;76(20):2334-48.10.1016/j.jacc.2020.09.549759876933129663 Search in Google Scholar

35. BELARTE-TORNERO LC., VALDIVIELSO-MORÉ S., VICENTE ELCANO M., SOLÉ-GONZÁLEZ E., RUÍZ-BUSTILLO S., CALVO-FERNÁNDEZ A., et al. Prognostic implications of chronic heart failure and utility of NT-proBNP levels in heart failure patients with SARS-CoV-2 infection. Journal of clinical medicine. 2021;10(2):323.10.3390/jcm10020323782989933477268 Search in Google Scholar

36. INCIARDI RM., ADAMO M., LUPI L., CANI DS., DI PASQUALE M., TOMASONI D., et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. European heart journal. 2020;41(19):1821-9.10.1093/eurheartj/ehaa388723920432383763 Search in Google Scholar

37. CHEN T., WU D., CHEN H., YAN W., YANG D., CHEN G., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj. 2020;368.10.1136/bmj.m1091719001132217556 Search in Google Scholar

38. YIN Y., ZHOU S., ZHANG X., LI Z., LIU X., JIANG C., et al. Critically ill patients with COVID-19 in China: A multicenter retrospective observational study. 2020.10.2139/ssrn.3562469 Search in Google Scholar

39. BAKER K., HANRATH A., SCHIM VAN DER LOEFF I., TEE S., CAPSTICK R., MARCHITELLI G. COVID-19 management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases centre: a detailed descriptive analysis. 2020: 2020.05.14.20100834. doi: 10.1101/2020.05.14.20100834%J.medRxiv. Ouvrir le DOISearch in Google Scholar

40. CARABALLO C., MCCULLOUGH M., FUERY MA., CHOUAIRI F., KEATING C., RAVINDRA NG., et al. COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system. PLoS One. 2020;15(9):e0238829.10.1371/journal.pone.0238829752690932997657 Search in Google Scholar

41. HENG G., MINGLI Z., JING D., YONG Z., WEI W., WEI Z., et al. Cardiac structural and functional characteristics in patients with coronavirus disease 2019: a serial echocardiographic study. medRxiv. 2020.10.1101/2020.05.12.20095885 Search in Google Scholar

42. GARIBALDI BT., FIKSEL J., MUSCHELLI J., ROBINSON M., ROUHIZADEH M., NAGY P., et al. Patient trajectories and risk factors for severe outcomes among persons hospitalized for COVID-19 in the Maryland/DC region. Medrxiv. 2020.10.1101/2020.05.24.20111864 Search in Google Scholar

43. LIAO X., CHEN H., WANG B., LI Z., ZHANG Z., LI W, et al. Critical care for severe COVID-19: a population-based study from a province with low case-fatality rate in China. medRxiv. 2020. Search in Google Scholar

44. PARANJPE I., RUSSAK AJ., DE FREITAS JK., LALA A., MIOTTO R., VAID A., et al. Clinical characteristics of hospitalized Covid-19 patients in New York City. MedRxiv. 2020. Search in Google Scholar

45. GIORGI ROSSI P., MARINO M., FORMISANO D., VENTURELLI F., VICENTINI M., GRILLI R. Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia. Italy medRxiv. 2020;2020(13.20063545).10.1101/2020.04.13.20063545 Search in Google Scholar

46. YANOVER C., MIZRAHI B., KALKSTEIN N., MARCUS K., AKIVA P., BARER Y., et al. What factors increase the risk of complications in SARS-CoV-2–infected patients? a cohort study in a Nationwide Israeli Health Organization. JMIR public health and surveillance. 2020;6(3):e20872.10.2196/20872745110932750009 Search in Google Scholar

47. ARGENZIANO MG., BRUCE SL., SLATER CL., TIAO JR., BALDWIN MR., BARR RG., et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. bmj. 2020;369.10.1136/bmj.m1996725665132471884 Search in Google Scholar

48. REILEV M., KRISTENSEN KB., POTTEGÅRD A., LUND LC., HALLAS J., ERNST MT., et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. International journal of epidemiology. 2020;49(5):1468-81.10.1093/ije/dyaa140749965732887982 Search in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo